Two Sigma Securities’s Phio Pharmaceuticals PHIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,224
Closed -$18.6K 2207
2026
Q1
$18.6K Buy
+15,224
New +$17.4K ﹤0.01% 1381
2024
Q3
Sell
-1,384
Closed -$8.62K 3459
2024
Q2
$8.62K Buy
+1,384
New +$9.05K ﹤0.01% 2822
2023
Q1
Sell
-182
Closed -$7.33K 3116
2022
Q4
$7.33K Sell
182
-25
-12% -$1.28K ﹤0.01% 2407
2022
Q3
$13K Buy
207
+112
+118% +$8.48K ﹤0.01% 2361
2022
Q2
$7K Sell
95
-120
-56% -$11.3K ﹤0.01% 2090
2022
Q1
$21K Buy
215
+41
+24% +$3.9K ﹤0.01% 1973
2021
Q4
$19K Buy
+174
New +$27.7K ﹤0.01% 1412
2021
Q3
Sell
-158
Closed -$39K 1841
2021
Q2
$39K Buy
+158
New +$38.9K ﹤0.01% 1412
2019
Q3
Sell
-8
Closed -$18K 2358
2019
Q2
$18K Buy
8
+3
+60% +$7.87K ﹤0.01% 1958
2019
Q1
$15K Buy
+5
New +$11.2K ﹤0.01% 1696
2018
Q4
Sell
-2
Closed -$16K 2674
2018
Q3
$16K Buy
+2
New +$18.8K ﹤0.01% 2468
2018
Q1
Sell
-1
Closed -$23K 2884
2017
Q4
$23K Hold
1
﹤0.01% 1619
2017
Q3
$28K Hold
1
﹤0.01% 796
2017
Q2
$19K Hold
1
﹤0.01% 784
2017
Q1
$39K Buy
+1
New +$43.2K 0.01% 820
2016
Q2
Hold
0
-$4K 499
2016
Q1
Hold
0
282

Other funds holding PHIO

Two Sigma Securities's PHIO Position: Q2 2026 in Review

Two Sigma Securities sold out of Phio Pharmaceuticals (PHIO) in Q2 2026, closing a stake of 15,224 shares — an estimated $18.6K sold.

Two Sigma Securities first reported a position in PHIO in Q1 2017 and held it in 15 quarters. The position peaked at $39K in Q2 2021. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

  • Two Sigma Securities reported no remaining Phio Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 15,224 Phio Pharmaceuticals shares in Q2 2026, an estimated $18.6K.
  • Two Sigma Securities first reported a position in Phio Pharmaceuticals in Q1 2017 and held it in 15 quarters.
  • Two Sigma Securities's Phio Pharmaceuticals position peaked at $39K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.